BIOMAT Database Logo BIOMAT Database Logo

Cathelicidin administration protects mice from Bacillus anthracis spore challenge. 2008

Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Cathelicidins are a family of cationic peptides expressed in mammals that possess numerous bactericidal and immunomodulatory properties. In vitro analyses showed that human, mouse, and pig cathelicidins inhibited Bacillus anthracis bacterial growth at micromolar concentrations in the presence or absence of capsule. Combined in vitro analyses of the effects of each peptide on spore germination and vegetative outgrowth by time lapse phase contrast microscopy, transmission electron microscopy, and flow cytometric analysis showed that only the pig cathelicidin was capable of directly arresting vegetative outgrowth and killing the developing bacilli within the confines of the exosporium. C57BL/6 mice were protected from spore-induced death by each cathelicidin in a time- and dose-dependent manner. Protection afforded by the porcine cathelicidin was due to its bactericidal effects, whereas the human and mouse cathelicidins appeared to mediate protection through increased recruitment of neutrophils to the site of infection. These findings suggest that cathelicidins might be utilized to augment the initial innate immune response to B. anthracis spore exposure and prevent the development of anthrax.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000881 Anthrax An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics. Bacillus anthracis Infection,Bacillus anthracis Infections
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.
January 2015, PloS one,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
January 2013, PloS one,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
The Bacillus anthracis spore.
December 2009, Molecular aspects of medicine,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
August 2007, Infection and immunity,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.
March 2009, Proceedings of the National Academy of Sciences of the United States of America,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.
July 2003, Infection and immunity,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.
April 2013, Medical microbiology and immunology,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Morphogenesis of the Bacillus anthracis spore.
February 2007, Journal of bacteriology,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
March 2013, Biochimica et biophysica acta,
Mark W Lisanby, and Melissa K Swiecki, and Brian L P Dizon, and Kathryn J Pflughoeft, and Theresa M Koehler, and John F Kearney
YhgC protects Bacillus anthracis from oxidative stress.
September 2010, The International journal of artificial organs,
Copied contents to your clipboard!